Abstract:Often referred to as "second genome", human microbiome is at the epicenter of a complex inter-habitat biochemical network, such as the "gut-brain axis", which have emerged as significant determinant of cognition, nutrition, overall health and well being, as well as resistance to antibiotics and susceptibility to diseases. As part of a broader investigation on the causative effects of human microbiome on human health and disease, the pathophysical role of microbial interactions, wherein the encoded secondary metabolites (natural products) play crucial signalling roles, has been the subject of intense scrutiny in the recent past. A major focus of these activities is aimed towards harvesting the genomic potential of human microbiome via bioinformatics guided genome mining and culturomics. Through these efforts, an impressive number of structurally intriguing novel antibiotics, embodying a wider chemical diversity vis-à-vis conventional antibiotics, have been isolated from human commensal bacteria, enticing considerable interest in their total synthesis and expansion of the therapeutic chemical space towards drug discovery. These developments augur well for the discovery of new drugs and antibiotics, particularly in the context of emerging new diseases and handling the challenges of MDR, AMR and mycobacterial resistance, among others. The current landscape of various synthetic campaigns and drug discovery initiatives on antibacterial natural products derived from human microbiome is captured and elaborated in this review with the intent of cultivating further interest in this interdisciplinary arena and drawing the attention of a new generation of creative practitioners

Biosynthetic Gene Clusters in Bacteria: A Review

Gene Cluster Analysis for the Biosynthesis of Elgicins, Novel Lantibiotics Produced by Paenibacillus Elgii B69

The Biosynthetic Gene Clusters of Aminocoumarin Antibiotics

The “Three Cs” of Novel Antibiotic Discovery and Production through Synthetic Biology: Biosynthetic Gene Clusters, Heterologous Chassis, and Synthetic Microbial Consortia

Insights into secondary metabolism from a global analysis of prokaryotic biosynthetic gene clusters

Genome Mining Reveals Novel Biosynthetic Gene Clusters in Entomopathogenic Bacteria

Antibiotic dialogues: induction of silent biosynthetic gene clusters by exogenous small molecules

Molecular and biotechnological aspects of secondary metabolites in actinobacteria

Do Global Regulators Hold the Key to Production of Bacterial Secondary Metabolites?

Secondary metabolic pathway genes and new drug discovery

Genome mining of biosynthetic and chemotherapeutic gene clusters in Streptomyces bacteria

Global Analysis of Biosynthetic Gene Clusters Reveals Conserved and Unique Natural Products in Entomopathogenic Nematode-Symbiotic Bacteria

Exploring Newer Biosynthetic Gene Clusters in Marine Microbial Prospecting

Combinatorial biosynthesis of novel aminoglycoside antibiotics via pathway engineering

Genome Mining Enabled by Biosynthetic Characterization Uncovers a Class of Benzoxazolinate‐Containing Natural Products in Diverse Bacteria

A Natural Product Chemist's Guide to Unlocking Silent Biosynthetic Gene Clusters

Streptomyces: The biofactory of secondary metabolites

An atlas of bacterial secondary metabolite biosynthesis gene clusters

Natural products from human microbiome: an emergent frontier in organic synthesis and drug discovery

Whole-Genome Sequencing And Characterization Of Two Bacillus velezensis Strains from Termitarium and A Comprehensive Comparative Genomic Analysis of Biosynthetic Gene Clusters

The Termite Nest-Associated Bacterium Brevibacillus parabrevis WGTm-23 Contains Unique Biosynthetic Gene Clusters Potentially Coding for Novel Antimicrobial Agents